Effect of selective blockade of endothelin ET(B) receptors on the liver dysfunction and injury caused by endotoxaemia in the rat

British Journal of Pharmacology

Volumn 119, Issue 3, 1996, Pages 479-486

  Ruetten, Hartmut ^a   Thiemermann, Christoph ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

BQ 485; BQ 788; Endothelin receptors ET(A) and ET(B); Endotoxic shock; Multiple organ failure; Vascular hyporeactivity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BACTERIAL POLYSACCHARIDE; BILIRUBIN; CREATININE; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; GAMMA GLUTAMYLTRANSFERASE; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; NITRITE; NORADRENALIN; PERHYDRO 1 AZEPINYLCARBONYLLEUCYL DEXTRO TRYPTOPHYL DEXTRO TRYPTOPHAN; UNCLASSIFIED DRUG; UREA;

ACID BASE BALANCE; ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOTOXEMIA; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; LIVER DYSFUNCTION; LIVER INJURY; MALE; METABOLIC ACIDOSIS; MULTIPLE ORGAN FAILURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; SEPTIC SHOCK; UREA BLOOD LEVEL;

EID: 0029836283     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15697.x     Document Type: Article

References (46)

1. ALLCOCK, G.H., WARNER, T.D. & VANE, J.R. (1995). Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists. Br. J. Pharmacol., 116, 2482-2486.
2. ARAI, H., HORI, S., ARAMORI, I., OHKOBO, H. & NAKANISHI, S. (1990). Cloning and expression of a cDNA encoding an endothelin receptor. Nature, 348, 730-732.
3. BANKEY, P.E. & CERRA, F.B. (1993). Hepatic dysfunction in shock and organ failure. In Pathophysiology of Shock, Sepsis, and Organ Failure. ed. Schlag, G. & Redl, H. pp. 948-960, Berlin: Springer Verlag.
4. BAUE, A.E. (1993). The multiple organ or system failure syndrome. In Pathophysiology of Shock, Sepsis, and Organ Failure. ed. Schlag, G. & Redl, H., pp. 1004-1018, Berlin: Springer Verlag.
5. BAUER, M., ZHANG, J.X., BAUER, I. & CLEMENS, M.G. (1994). Endothelin-1 induced alterations of hepatic microcirculation: sinusoidal and extrasinusoidal sites of action. Am. J. Physiol., 267, G143-G149.
6. 1,3,11,15] endothelin-1 by BQ-123 in the anaesthetised rat. Br. J. Pharmacol., 107, 912-918.
7. DE KIMPE, S.J., HUNTER, M.L., BRYANT, C.E., THIEMERMANN, C. & VANE, J.R. (1995). Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphyloccocus aureus in anaesthetised rats. Br. J. Pharmacol., 114, 1317-1323.
8. DE NUCCI, G., THOMAS, G.R., D'ORLEANS-JUSTE, P., ANTUNES, E., WALDER, C., WARNER, T.D. & VANE, J.R. (1988). The pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. U.S.A., 85, 9797-9800.
9. DAVENPORT, A.P., O'REILLY, G. & KUC, R.E. (1995). Endothelin ET(a) and ET(b) mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ET(a) sub-type. Br. J. Pharmacol., 114, 1110-1116.
10. DOUGLAS, S.A., GELLAI, M., EZEKIEL, M., FEUERSTEIN, G.Z., ELLIOTT, J.D. & OHLSTEIN, E.H. (1995). Antihypertensive actions of the novel nonpeptide endothelin receptor antagonist SB 209670. Hypertension, 25, 818-822.
11. FUKURODA, T., FUJIKAWA, T., OZAKI, S., ISHIKAWA, K., YANO, M. & NISHIKIBE, M. (1994). Clearance of circulating endothelin-1 by ETB receptors in the rat. Biochem. Biophys. Res. Commun., 199, 1461-1465.
12. GARDINER, S.M., KEMP, P.A., MARCH, J.E. & BENNETT, T. (1995). Enhancement of the hypotensive and vasodilator effects of endotoxaemia in conscious rats by the endothelin antagonist, SB 209670. Br. J. Pharmacol., 116, 1718-1719.
13. GREEN, L.C., TANNENBAUM, S.R. & GOLDMAN, P. (1981). Nitrate synthesis in the germfree and conventional rat. Science, 212, 56-58.
14. G-methylarginine. Biochem. Biophys. Res. Commun., 170, 96-103.
15. HOUSSET, C., ROCKEY, D.C. & MONTGOMERY BISSELL, D. (1993). Endothelin receptors in the rat liver: Lipocytes as a contractile target for endothelin-1. Proc. Natl. Acad. Sci. U.S.A., 90, 9266-9270.
16. IHARA, M., SAEKI, T., FUNABASHI, K., NAKAMICHI, K., YANO, M., FUKURODA, T., MIYAJI, M., NISHIKIBE, M. & IKEMOTO, F. (1991). Two endothelin receptor subtypes in porcine arteries. J. Cardiovasc. Pharmacol., 17, (Suppl. 17), S119-121.
17. B receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. U.S.A., 91, 4892-4896.
18. KURIHARA, T., AKIMOTO, M., KUROKAWA, K., ISHIGURO, H., NIIMI, A., MAEDA, A., SIGEMOTO, M., YAMASHITA, K., YOKOYAMA, I., HIRAYAMA, Y., IHARA, M. & YANO, M. (1992). ET-3 sensitive reduction in tissue blood flow in rat liver. Life Sci., 51, 101-106.
19. MCCLUSKEY, R.S. & REILLY, F.D. (1993). Hepatic microvasculature: dynamic structure and its regulation. Semin. Liver Dis., 13, 1-12.
20. MILLER, C.G.M. & THIEMERMANN, C. (1996). Nitric oxide, septic shock and acute renal failure. In Nitric Oxide in the Kidney. ed. Goligorski, M.S., Philadelphia: W.B. Saunders (in press).
21. MOREL, D.R., LACROIX, J.S., HEMSEN, A., STEINIG, D.A., PITTET, J.F. & LUNDBERG, J.M. (1989). Increased plasma and pulmonary lymph levels of endothelin during endotoxin shock. Eur. J. Pharmacol., 167, 427-428.
22. NAKAHASHI, T., FUKUO, K., INOUE, T., MORIMOTO, S., HATA, S., YANO, M. & OGIHARA, T. (1995). Endothelin-1 enhances nitric oxide-induced cytotoxicity in vascular smooth muscle. Hypertension, 25, 744-747.
23. NAKAMURA, T., KASAI, K., SEKIGUCHI, Y., BANBA, N., TAKAHASHI, K., EMOTO, T., HATTORI, Y. & SHIMODA, S. (1991). Elevation of plasma endothelin concentration during endotoxin shock in dogs. Eur. J. Pharmacol., 205, 277-282.
24. OHLSTEIN, E.H., NAMBI, P., DOUGLAS, S.A., EDWARDS, R.M., GELLAI, M., LAGO, A., LEBER, J.D., COUSINS, R.D., GAO, A., FRAZEE, J.S., PEISHOFF, C.E., BEAN, J.W., EGGLESTON, D.S., ELSHOURBAGY, N.A., KUMAR, C. LEE, J.A., YUE, T.L. LOUDEN, C. BROOKS, D.P., WEINSTOCK, J., FEUERSTEIN, G., POSTE, G., RUFFOLO, R.R., GLEASON, J.G. & ELLIOTT, J.D. (1994). SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist. Proc. Natl. Acad. Sci. U.S.A., 91, 8052-8056.
25. OKUMURA, S., TAKEI, Y., KAWANO, S., NAGANO, K., MASUDA, E., GOTO, M., TSUJI, S., MICHIDA, T., CHEN, S., KASHIWAGI, T., FUSAMOTO, H., KAMADA, T. & SATO, N. (1994). Vasoactive effect of endothelin-1 on rat liver in vivo. Hepatology, 19, 155-161.
26. PERNOW, J., HEMSEN, A. & LUNDBERG, J.M. (1989). Increased plasma levels of endothelin-like immunoreactivity during endotoxin administration in the pig. Acta Physiol. Scand., 137, 317-318.
27. PINZANI, M., MILANI, S., DE FRANCO, R., GRAPPONE, C., CALIGIURI, A., GENTILINI, A., TOSTI-GUERRA, C., MAGGI, M., FAILLI, P., RUOCCO, C. & GENTILINI, P. (1996). Endothelin-1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology, 110, 534-548.
28. PITTET, J.F., MOREL, D.R., HEMSEN, A., GUNNING, K., LACROIX, J.S., SUTER, P.M. & LUNDBERG, J.M. (1991). Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann. Surg., 213, 261-264.
29. RAMADORI, G. (1991). The stellate cell (Ito, fat-storing cell, lipocyte, perisinusidal cell) of the liver: new insights into pathophysiology of an intriguing cell. Virchows Arch. B Cell. Pathol., 61, 147-158.
30. RAMADORI, G., VEIT, T., SCHWOGLER, S., DIENES, P., KNITTEL, T., RIEDER, H. & MEYER ZUM BUSCHENFELDE, K.H. (1990). Expression of the gene of the α-smooth muscle-actin isoform in rat liver and rat fat-storing Ito cells. Virchows Arch. B Cell. Pathol., 59, 349-357.
31. ROCKEY, D.C. (1995). Characterization of endothelin receptors mediating rat hepatic stellate cell contraction. Biochem. Biophys. Res. Commun., 207, 725-731.
32. ROCKEY, D.C., HOUSSET, C.N. & FRIEDMAN, S.L. (1993). Activation-dependent contractivity of rat hepatic lipocytes in culture and in vivo. J. Clin. Invest., 92, 1795-1804.
33. RUETTEN, H., THIEMERMANN, C. & VANE, J.R. (1996). Blockade of endothelin receptors with SB 209670 aggravates the circulatory failure and the organ injury in endotoxic shock in the anaesthetised rat. Br. J. Pharmacol., (in press).
34. SAKAMOTO, M. (1991). Effect of endothelin-1 on the contraction of Ito cells (fat-storing cells). Acta Hepatol. Jpn., 32, 1027-1033.
35. SAKURAI, T., YANAGISAWA, M., TAKUWA, Y., MIYAZAKI, H., KIMURA, S., GOTO, K. & MASAKI, T. (1990). Cloning of a cDNA encoding a non-isopeptide selective subtype of the endothelin receptor. Nature, 348, 732-735.
36. SUGIURA, M., INAGAMI, T. & KON, V. (1989). Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem. Biophys. Res. Commun., 161, 1220-1227.
37. SZABO, C., MITCHELL, J.A., THIEMERMANN, C. & VANE, J.R. (1993). Nitric-oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br. J. Pharmacol., 108, 786-792.
38. TAKAKUWA, T., ENDO, S., NAKAE, H., KIKICHI, M., SUZUKI, T., INADA, K. & YOSHIDA, M. (1994). Plasma levels of TNF-α. endothelin-1 and thrombomodulin in patients with sepsis. Res. Comm. Chem. Pathol. Pharmacol., 84, 261-269.
39. TEERLINK, J.R., BREU, V., SPRECHER, U., CLOZEL, M. & CLOZEL, J.P. (1994). Potent vasoconstriction mediated by endothelin ETB receptors in canine coronary arteries. Circ. Res., 74, 105-114.
40. THIEMERMANN, C., LIDBURY, P.S., THOMAS, G.R. & VANE, J.R. (1989). Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anaesthetized rabbit. J. Cardiovasc. Pharmacol., 13 (Suppl. 5), S138-S141.
41. THIEMERMANN, C., RUETTEN, H., WU, C.C. & VANE, J.R. (1995). The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br. J. Pharmacol., 116, 2845-2851.
42. THIEMERMANN, C., SZABO, C., MITCHELL, J.A. & VANE, J.R. (1993). Vascular hyporeactivity to vasoconstrictor agents and hemodynamics decompensation in hemorrhagic shock is mediated by nitric oxide. Proc. Natl. Acad. Sci. U.S.A., 90, 267-271.
43. WARNER, T.D. (1993). Characterisation of endothelin synthetic pathways and receptor subtypes: physiological and pathophysiological implications. Eur. Heart J., 14 (Suppl. 1), 42-47.
44. YANAGISAWA, M. & MASAKI, T. (1989). Molecular biology and biochemistry of endothelin. Trends Pharmacol. Sci., 10, 374-378.
45. ZHANG, J.X., PEGOLI, W. & CLEMENS, M.G. (1994). Endothelin-1 induces direct constriction of hepatic sinusoids. Am. J. Physiol., 266, G624-G632.
46. ZHANG, J.X., BAUER, M. & CLEMENS, M.G. (1995). Vessel- and target cell-specific actions of endothelin-1 and endothelin-3 in rat liver. Am. J. Physiol., 269, G269-G277.